1 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
| 1 | 32694423 | A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. | 2020 Nov | 1 |